Inventor · disambiguated record
Dingguo Liu
Also filed as: LIU DINGGUO
9 granted patents·10 pending applications·17 citations·filing 2005–2023
82Inventor score
Files withBIONECURE THERAPEUTICS INC3BRADSHAW CURT W3SOLSTICE BIOLOGICS LTD3DOPPALAPUDI VENKATA RAMANA2SIRIUS THERAPEUTICS INC2
Top patents by PatentIndex Score
19 records- 0184US11203611B2Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their useSOLSTICE BIOLOGICS LTD·Filed 2018·Granted Dec 21, 2021·5 cites·35 claims
- 0281US11597744B2Chiral phosphoramidite auxiliaries and methods of their useSIRIUS THERAPEUTICS INC·Filed 2018·Granted Mar 7, 2023·2 cites·20 claims
- 0379US8288349B2Anti-angiogenic compoundsBRADSHAW CURT WILLIAM·Filed 2007·Granted Oct 16, 2012·7 cites·29 claims
- 0473US12269839B2Chiral phosphoramidite auxiliaries and methods of their useSIRIUS THERAPEUTICS INC·Filed 2023·Granted Apr 8, 2025·0 cites·13 claims
- 0572US8293714B2Anti-angiogenic compoundsDOPPALAPUDI VENKATA RAMANA·Filed 2009·Granted Oct 23, 2012·2 cites·33 claims
- 0666US12351598B2Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their useTALLAC THERAPEUTICS INC·Filed 2021·Granted Jul 8, 2025·0 cites·44 claims
- 0765US8937048B2Anti-angiogenic compoundsDOPPALAPUDI VENKATA RAMANA·Filed 2012·Granted Jan 20, 2015·1 cites·22 claims
- 0854US2015057431A1Compositions for treating a disease or condition associated with abnormal angiogenesisCOVX TECHNOLOGIES IRELAND LTD·Filed 2014·Application pending·0 cites
- 0953US2020392498A1Polynucleotide constructs having bioreversible and non-bioreversible groupsSOLSTICE BIOLOGICS LTD·Filed 2020·Application pending·0 cites
- 1052US9797627B2District public water supply pipe network system compatible for source side water for ground source heat pump system and reclaomed waterTIANJIN GERUISI NEW TECH OF MECH AND ELECTRICAL CO LTD·Filed 2014·Granted Oct 24, 2017·0 cites·20 claims
- 1151US2024101717A1Anti-her-2/trop-2 constructs and uses thereofBIONECURE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1248US2023256114A1Novel maytansinoids as adc payloads and their use for the treatment of cancerBIONECURE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1347US8912148B2Methods of treating a disease or condition associated with abnormal angiogenesisBRADSHAW CURT·Filed 2012·Granted Dec 16, 2014·0 cites·24 claims
- 1447US2023235080A1Trophoblast cell-surface antigen-2 (trop-2) antibodiesBIONECURE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1543US2016257961A1Polynucleotide constructs having disulfide groupsBRADSHAW CURT W·Filed 2014·Application pending·0 cites
- 1643US2017114341A1Polynucleotide constructs having bioreversible and non-bioreversible groupsBRADSHAW CURT W·Filed 2015·Application pending·0 cites
- 1739US2019194655A1Polynucleotide constructs having an auxiliary moiety non-bioreversibly linked to an internucleoside phosphate or phosphorothioateBRADSHAW CURT W·Filed 2016·Application pending·0 cites
- 1837US2006025474A1Bisphenyl compounds useful as vitamin D3 receptor agonistsWALLACE DAVID·Filed 2005·Application pending·0 cites
- 1928US2018346505A1Mononucleotides having a bioreversible disulfide groupSOLSTICE BIOLOGICS LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dingguo Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →